v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows - operating activities    
Net earnings $ 1,724 $ 1,936
Adjustments to reconcile net earnings to cash provided from operating activities    
Provision for credit losses 2,637 3,575
Deferred income taxes 31 (8)
Depreciation and amortization 247 240
(Increase) decrease in interest and fees receivable (65) 209
(Increase) decrease in other assets (9) (120)
Increase (decrease) in accrued expenses and other liabilities (85) (239)
Gain on sale of business 0 (1,069)
All other operating activities 280 208
Cash provided from (used for) operating activities 4,760 4,732
Cash flows - investing activities    
Maturity and sales of debt securities 1,205 2,196
Purchases of debt securities (1,006) (1,047)
Acquisitions, net of cash acquired 0 (1,935)
Proceeds from sale of business, net of cash and restricted cash sold 0 491
Net (increase) decrease in loan receivables, including held for sale 1,607 (1,092)
All other investing activities (444) (322)
Cash provided from (used for) investing activities 1,362 (1,709)
Borrowings of consolidated securitization entities    
Proceeds from issuance of securitized debt 1,495 947
Maturities and repayment of securitized debt (1,000) (700)
Senior and subordinated unsecured notes    
Proceeds from issuance of senior unsecured notes 794 0
Maturities and repayment of senior unsecured notes (750) (600)
Dividends paid on preferred stock (42) (30)
Proceeds from Issuance of Preferred Stock and Preference Stock 0 488
Net increase (decrease) in deposits 195 1,938
Purchases of treasury stock (1,109) (605)
Dividends paid on common stock (211) (202)
All other financing activities (70) 1
Cash provided from (used for) financing activities (698) 1,237
Increase (decrease) in cash and equivalents, including restricted amounts 5,424 4,260
Cash and equivalents, including restricted amounts, at beginning of period 14,755 14,420
Cash and equivalents 19,457 18,632
Restricted cash and equivalents included in other assets 722 48
Total cash and equivalents, including restricted amounts, at end of period $ 20,179 $ 18,680